APAC CIOOutlook
About UsConferencePartner With Us
  • Technologies
    • Blockchain
      Data Intelligence and Management
      Digital Transformation
      FinTech
      Generative and Agentic AI
      Low Code No Code
      Mobile Application
      Networking
      Robotics
      Storage
      Wireless
  • Industries
    • Automotive
      Aviation
      Banking
      Construction
      E-Commerce
      Food and Beverages
      Healthcare
      Insurance
      Logistics
      Manufacturing
      Retail
      Supply Chain
      Travel and Hospitality
  • Platforms
    • Microsoft
      Salesforce
      SAP
  • Strategic Solutions
    • Business Intelligence
      Contact Center
      Corporate Finance
      CRM
      Cyber Security
      Data Center
      Enterprise Asset Management
      Enterprise Performance Management
      IT Infrastructure and Services
      Managed Services
      Procurement
      Unified Communication
      Workflow
  • Home
  • CXO Insights
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Whitepapers
  • CXO Awards
#

Apac CIOOutlook Weekly Brief

×

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

Subscribe

loading

THANK YOU FOR SUBSCRIBING

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by the Construction Tech Review Advisory Board.

Jubilant Life Sciences Limited

Umesh Mehta, CIO

Technology Vacuum yet to be filled in Pharmaceutical & Life Sciences

Umesh Mehta

Umesh Mehta

To date, the cloud market has mainly served as a tool for sales and marketing teams within most pharmaceutical companies. But that is quickly changing. Today, the cloud market is adapting to meet the needs of all areas within life sciences. It not only helps them to overcome IP issues and security issues, but also allowed countless companies to cut down operational costs. "Platform as a Service" or PaaS is a complete, pre-integrated platform that facilitates the deployment of applications without the cost and complexity of buying and managing underlying hardware, software or hosting capabilities.

Mobility is another gift technology has brought to pharmaceutical companies. Mobility helps in having greater visibility of field force especially in remote areas and to respond quickly and in timely manner to the end users. It does helps to pre-call planning, in-clinic effectiveness, capture real time information, and real time monitoring with the concept of anytime & anywhere. It does help to get socialize with the end customer on real time which has a positive impact on customer delight and also to increase the productivity.

Though basic core systems like ERP, Supply Chain Management and CRM has improved the productivity of the industry, lot needs to be done on R&D, regulatory and compliance part. To improve the productivity, pharmaceutical companies should implement solutions like Product Life Cycle Management, Manufacturing Execution System, Quality Management Systems, Advance planning and scheduling among others.

IT can play a big role in addressing the challenges of Pharmaceutical & Life Science companies around profitable growth, regulatory compliance, and operational through various generic and industry specific solutions.

Challenges in New Vertical

Unlike Automotive industry, penetration of IT in Pharmaceutical & Life Sciences industry
was much less. IT was never looked at as a key business driver, thus pharmaceutical companies were slow in adopting Information Technology. Technology mainly was adopted to meet regulatory requirements or there existed a dire need for business to do so. There were challenges around standardization of master data, processes and reports; data from various applications was not getting converted into meaningful and actionable information.

As a CIO, change management has always been a challenging task. To implement IT based solutions to solve business challenges in such industry is not that simple. Involving stakeholder from the very beginning including during selection of the technology platform and showing them benefits (What is there in the solutions for them) always helps in winning confidence of the stakeholders. Such steps help in overcoming the issues of change management and in deploying as well as using technology based solutions.

Previous result-driven professional experience has helped in winning credibility and confidence of the internal customers within a short span of time. The approach to target low hanging fruits (quick wins) and gain credibility by constantly delivering results has made the internal customer and stakeholder ready for jointly taking up complex and large functional and cross functional IT projects. Having prior experience of setting up IT Infrastructure from scratch for 4 out of the 5 organizations has really helped in streamlining IT infrastructure at Jubilant. It gave very good results in terms of the IT services uptime in a short time and also helped in reducing the OPEX cost.

Apart from the Pharmaceutical industry's regulatory and GMP (Good Manufacturing Practices) requirements, it was not very complex to blend generic technology solutions in Pharmaceutical & Life Science companies, given that most of the processes in Pharmaceutical industry are similar to process-manufacturing organization. Specialized pharmaceutical industry specific solutions are also available in the market to suit industry requirements.

As of now, penetration of IT is low in Pharmaceutical industry compared to industries like BFSI, Telecom and Automotive. On a positive note, there is a lot of scope for emerging technologies like mobile, cloud, social and analytics to improve productivity, reduce cost, meet regulatory requirements and mitigate risk. (As told to Susila Govindaraj).


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping construction technology and innovation. Participation is by invitation only. It features leaders who are not merely observing technological change, but actively contributing to it through digital transformation and execution-driven insights.
EDITOR'S CHOICE
  • Willis Towers Watson

    ISS Facility Services Australia & New Zealand

    The Right Technology And Reliable Partners; The Business Next Frontier

    Luke O'Brien, CIO

  • Willis Towers Watson

    BPAY Group

    Building BPAY Group's New Digital Foundation

    Angela Donohoe, Chief Information Officer

  • Willis Towers Watson

    Bvn Architecture

    How Have Recent Advancements in Big Data Been Impacting Businesses?

    Marc Solomon, CIO

  • Willis Towers Watson

    Tassal Operations

    BI & Analytics in Aquaculture

    Matthew Leary, CIO

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

APAC CIOOutlook
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@apacciooutlook.com
  • sales@apacciooutlook.com
  • marketing@apacciooutlook.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 APAC CIOOutlook. All rights reserved. Headquarteblue in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.apacciooutlook.com/cxoinsights/technology-vacuum-yet-to-be-filled-in-pharmaceutical-life-sciences-nwid-1230.html